Literature DB >> 20737180

Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.

Kumar Abhinav1, Laura Marsh, Barbara Crain, Stephen G Reich, Kevin Biglan.   

Abstract

Idiopathic Parkinson's disease (PD) and progressive supranuclear palsy (PSP) are distinct clinicopathological entities characterized by α-synuclein and tau pathology, respectively. They have occasionally been reported to co-exist in the same patient. We describe a rare case of a 73-year-old Caucasian woman diagnosed as idiopathic PD 5 years before her death yet at autopsy had not only PD, but also PSP. Although this patient fulfilled clinical criteria for idiopathic PD and did not have supranuclear ophthalmoplegia, she had several atypical features, including early postural instability with falls, early dysphagia, and a relatively rapid course. In conclusion, this case and a literature review highlight the co-existence of synuclein and tau pathology in the same patient and demonstrate that multiple diagnoses may exist in patients presenting with parkinsonism. The clinical heterogeneity seen in parkinsonism may reflect the occurrence of combined pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20737180     DOI: 10.1007/s10072-010-0386-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

2.  Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.

Authors:  Kurt A Jellinger
Journal:  Neurodegener Dis       Date:  2008-03-18       Impact factor: 2.977

Review 3.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

4.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

5.  Lewy bodies in progressive supranuclear palsy.

Authors:  Hideo Mori; Masaya Oda; Takashi Komori; Nobutaka Arai; Masashi Takanashi; Toshio Mizutani; Shunnichi Hirai; Yosikuni Mizuno
Journal:  Acta Neuropathol       Date:  2002-05-04       Impact factor: 17.088

6.  Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.

Authors:  Takashi Ishizawa; Petri Mattila; Peter Davies; Dengshun Wang; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

7.  Parkinson's Disease Society Brain Bank, London: overview and research.

Authors:  S E Daniel; A J Lees
Journal:  J Neural Transm Suppl       Date:  1993

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Diffuse Lewy body disease presenting with a supranuclear gaze palsy.

Authors:  J M Fearnley; T Revesz; D J Brooks; R S Frackowiak; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

10.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

View more
  2 in total

1.  Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.

Authors:  Heather B Rigby; Brittany N Dugger; Joseph G Hentz; Charles H Adler; Thomas G Beach; Holly A Shill; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; John N Caviness
Journal:  Mov Disord Clin Pract       Date:  2014-10-29

2.  Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.

Authors:  María Elena Erro Aguirre; María Victoria Zelaya; Javier Sánchez Ruiz de Gordoa; María Teresa Tuñón; José Luis Lanciego
Journal:  Front Neuroanat       Date:  2015-03-11       Impact factor: 3.856

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.